baber/WOPTO huggingface dataset:
Patent NZ-591941-A (NZ)
Title: Fly ash based lightweight cemen composition with high early compressive strength and fast set for wet locations
Inventor: PEREZ-PENA MARIANELA
IPC: C04B14/04
Filed: 2009-09-10
Abstract: A method of providing a fast setting cementitious mixture having high early compressive strength and moisture durability when used in wet locations is disclosed, wherein the method comprises the steps of: mixing water, reactive powder, an alkali metal salt of citric acid, and lightweight aggregate,wherein the weight ratio of water to reactive powder is about 0.17 to 0.35: 1.0, the reactive powder comprising 75 to 100 wt. % fly ash, and 0 to 25 wt. % non-fly ash mineral additive, hydraulic cement and gypsum, andwherein the mixture does not contain alkali metal hydroxides, and allowing the mixture to finally set for about 5 to 10 minutes from the time of mixing before handling the set cementitious mixture. .
Patent NZ-592896-A (NZ)
Title: Toothbrush head with tapered with and non-tapered bristles in tufts which are angled relative to the brush surface
Inventor: KRAEMER HANS
IPC: A46B9/02
Filed: 2009-12-14
Abstract: 592896 A toothbrush head (121) with bristle turfs (124) comprising tapered and non-tapered bristles extended from a bristle surface (123). The plural bristle tufts (124) comprise plural first tufts (1241) inclined at an acute angle 75-85° to the bristle surface. The tufts (124) further comprise plural second tufts (1242), widthways distanced from the first tufts (1241), the second tufts (1242) also being inclined at acute angle (A2) 75-85° to the bristle surface, with the plural second turfs being angled in a different direction to the first tufts with respect to the head (121). The non-tapered bristles extend to two different lengths from the face, being a first greater length (LN1) and a second shorter length (LN2).
Patent NZ-598144-A (NZ)
Title: Kinase inhibitors, prodrug forms thereof and their use in therapy
Inventor: SMAILL JEFFREY BRUCE
IPC: A61P35/00
Filed: 2010-09-02
Abstract: 598144 Disclosed herein are pyrido[3,4-d]pyrimidine compounds of formula (I) suitable as kinase inhibitors, kinase inhibitors in prodrug form, their use in compositions and medicaments which are suitable for the treatment of diseases related to kinase activity such as cancers. In one embodiment the compound is (2E)-4-({ 4-[3-chloro-4-(2-pyridinylmethoxy)anilino] pyrido[3,4-d]pyrimidin-6-yl} amino)-N,N-dimethyl-N-[(1-methyl-4-nitro-1H-imidazol-5-yl)methyl]-4-oxo-2-buten-1-ammonium bromide.
Patent NZ-602441-A (NZ)
Title: A fast dissolving pharmaceutical composition
Inventor: GUNJIKAR TEJAS
IPC: A61K38/095
Filed: 2011-03-28
Abstract: Disclosed herein is a pharmaceutical composition including a matrix carrying a pharmaceutically active ingredient, preferably desmopressin acetate, loratidine, famotidine, or montelukast sodium, wherein the matrix including inulin as a matrix forming agent and mannitol. Also disclosed is a process for the preparation of the above composition comprising: (a) preparing a solution comprising inulin and an active ingredient in a solvent; (b) freezing said solution; (c) subliming the solvent from the frozen solution, wherein the pharmaceutical composition so obtained is disintegrates within 10 seconds upon contact with an aqueous solution or with saliva.
Patent NZ-604257-A (NZ)
Title: Fibre-optic coil for fibre-optic gyroscope
Inventor: PI YABIN
IPC: G02B6/36
Filed: 2011-07-09
Abstract: 604257 Disclosed is a fibre-optic coil used for a fibre-optic gyroscope (FOGs), including a bobbin (10) and polarisation-maintaining optical fibres wound around the bobbin. The polarisation maintaining optical fibres form a polarization-maintaining optical fibre ribbon (6) and consists of 2xN polarisation-maintaining optical fibres bound together in parallel such that N = 1, 2, 3… This forms a polarisation-maintaining optical fibre ribbon (6) with 2xN cores. The polarisation maintaining optical fibre ribbon (6), after being wound, has heads and tails of adjacent fibres in the two ends thereof joined by melting, with the head end of a first fibre and the tail end of a last fibre being used respectively as the input end and the output end of the fibre-optic coil.
Patent NZ-605466-A (NZ)
Title: Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment
Inventor: DANHOF IVAN E
IPC: A61P31/18
Filed: 2011-07-20
Abstract: Disclosed is a pharmaceutical composition with two components for use in the treatment, amelioration of symptoms, or both of Acquired Immune Deficiency Syndrome (AIDS) or a HIV infection in a subject comprising: -a sterile injectable polymannan extract formulation comprising one or more aloe polysaccharides, wherein the aloe polysaccharides comprise molecular weights ranging from 50,000-10,000,000 Daltons in an amount sufficient to treat or ameliorate symptoms of Acquired Immune Deficiency Syndrome (AIDS) or a HIV infection; and a composition comprising: -one or more aloe anthraquinones, diacetyl anthraquinones, and combinations thereof; -a freeze dried aloe powder, an aloe juice, an aloe gel, or a combination wherein the powder is administered as is or after reconstitution in a liquid; and -one or more optional nutritional supplements selected from the group consisting of fatty acids, proteins, minerals and metals, vitamins, salts, amino acids, and one or more pharmaceutically acceptable excipients. Also disclosed is the use of such a composition for the manufacture of a medicament for treating, ameliorating symptoms or both of Acquired Immune Deficiency Syndrome (AIDS) or a HIV infection in a subject.
Patent NZ-607003-A (NZ)
Title: Intrinsically magnetic hydroxyapatite
Inventor: TAMPIERI ANNA
IPC: A61L27/12
Filed: 2011-07-28
Abstract: Abstract – 607003 Disclosed herein is a hydroxyapatite comprising calcium ions and phosphate ions in a crystal lattice, characterized in that it is doped with Fe2+ ions and Fe3+ ions, which partially substitute said calcium ions in said crystal lattice in a quantitative ratio Fe3+/Fe2+ of 1 to 4, has magnetism of 0.05 to 8emu/g, measured by applying a magnetic field of 34Oe, due to the presence of magnetic nano-domains in the lattice of hydroxyapatite, and comprises an amount of secondary magnetic phases below about 3 vol%.
Patent NZ-614175-A (NZ)
Title: Method or system for minimizing the impact of back emf sampling for motor resistance profiling
Inventor: PETTIGREW WARREN GORDON
IPC: H02P7/00
Filed: 2012-08-13
Abstract: Disclosed is a method of determining when to utilise a back EMF sampling method for motor resistance profiling in at least one brushed DC motor. The method includes the steps of analysing a parameter prior to initialising the back EMF sampling method; and initialising the back EMF sampling method upon a determination that the analysed parameter is within a defined range.
Patent NZ-625440-A (NZ)
Title: Anti-cxcr1 compositions and methods
Inventor: WICHA MAX S
IPC: G01N33/574
Filed: 2009-11-11
Abstract: Disclosed is the use of a compound for the preparation of a medicament for treating a subject having a tumour, wherein said compound is a CXCR1 antagonist and is formulated for use in combination with a chemotherapeutic drug.
Patent NZ-629888-A (NZ)
Title: Antibodies to matrix metalloproteinase 9
Inventor: MCCAULEY SCOTT
IPC: C12N9/64
Filed: 2012-02-29
Abstract: Disclosed is a method of detecting human MMP9 in a sample, comprising: a) contacting the sample with an antibody or antigen-binding fragment thereof comprising a heavy chain variable (VH) region and a light chain variable (VL), wherein the heavy chain variable region comprises a CDR1 comprising the amino acid sequence set forth in SEQ ID NO: 34, a CDR2 comprising the amino acid sequence set forth in SEQ ID NO: 35, and a CDR3 comprising the amino acid sequence set forth in SEQ ID NO: 36; wherein the light chain variable domain (VL) comprises a CDR1 comprising the amino acid sequence set forth in SEQ ID NO: 37, a CDR2 comprising the amino acid sequence set forth in SEQ ID NO: 38, and a CDR3 comprising the amino acid sequence set forth in SEQ ID NO: 39; and b) detecting binding of the antibody or antigen-binding fragment thereof to human MMP9 in the sample, thereby detecting the presence or absence of the human MMP9.
Patent NZ-630069-A (NZ)
Title: Entranceway for crustacean or fish trap
Inventor: BEVAN RICHARD POTTS
IPC: A01K75/00
Filed: 2014-09-03
Abstract: An entranceway for crustacean traps and fish traps is disclosed. The entranceway includes multiple rigid or semi-rigid fingers (6) located within a housing (7) or housings. The fingers define a funnel-shaped or tube-shaped entrance to the trap when fishing, but can be folded back away from the entrance opening towards the face of the trap upon which the entrance is located, by rotating the fingers within their housings. This is advantageous for ease of access to the interior of the trap, enabling the emptying of its contents via the entrance opening or enabling the trap to be collapsed to its minimum practicable dimensions.
Patent NZ-702605-A (NZ)
Title: Separator device for heating system
Inventor: ADEY CHRISTOPHER
IPC: F24D19/00
Filed: 2013-05-21
Abstract: A separator device (10) for removing particles from suspension in a fluid comprises: a housing (12), having first and second apertures (96) for ingress and egress of fluid into and out of the housing (12); a first separator chamber (38) disposed at one end of the housing; a second separator chamber (40) disposed at the other end of the housing, and a central chamber disposed between the first and second separator chambers (38, 40), the first and second separator chambers (38, 40) being apertured for ingress and egress of fluid from the central chamber and each containing obstruction means to slow the flow of fluid within the chamber.
Patent NZ-707334-A (NZ)
Title: Disc tumbler cylinder lock and key combination
Inventor: MALINEN PERTTU
IPC: E05B29/00
Filed: 2013-07-04
Abstract: In disc tumbler cylinder locks, rotatable tumbler discs are used to resolve a key-specific code and open the lock. It is the turning of the key that causes turning of the tumbler discs according to the millings of the key and thus resolution of the key code. If a key is, for some reason, not fully inserted into a disc tumbler cylinder lock, then there can be a very slight turning of the tumbler discs away from their common starting position. In this case, inserting the key will be experienced as difficult or impossible. To prevent this, disc tumbler cylinder locks are often provided with a rotation limiter which is a mechanism that prevents a key from turning in a disc tumbler cylinder lock if the key is not fully inserted. The rotation limiter also prevents removal of the key from the lock cylinder other than in the starting position. Although known rotation limiters are suitable for wide use in disc tumbler cylinder locks they are not used in all types of cylinders. Current rotation limiters are fitted on a case-by-case basis to given cylinder types. Additionally, constraints are perceived in the production of a cylinder lock without a rotation limiter or as provided with a rotation limiter. The present invention aims to reduce or remove the problems of the known art and relates to a disc tumbler cylinder lock and key combination, in which the tumbler discs of the cylinder lock are rotatable by a key. In a solution according to the invention, the rotation limiter disc means (10) of a disc tumbler cylinder lock-key-combination are arranged to be rotated by a key (11), wherein the rotation limiting means have no pieces non-rotatably attached to the inner cylinder (1). The rotation limiter disc means (10) are composed of a frame piece (10B) and a limiter piece (10A). The frame piece (10B) is a circular disc having an opening (53) in the middle of the disc. The opening extends up to the border (52) of the disc widening towards the border, and to the section on the wider side of the opening is disposed a limiter piece (10A). On the inner surface (62) of the inner cylinder (1) is a recess (25) at the site of the limiter disc means (10). The key (11) has at least one bevel-edged cavity (12).
Patent NZ-709835-A (NZ)
Title: Tricyclic heterocyclic compounds and jak inhibitors
Inventor: NASU MARIKO
IPC: C07D513/14
Filed: 2012-08-10
Abstract: Provided are tricyclic pyrimidine and pyridine compounds of the general formulae (Ia) and (Ib), where the variables are as defined in the specification. Examples of the compounds include 2-(4-{ [4-(7H-pyrrolo[3,2-e][1,2,3]triazolo[1,5-c]pyrimidin-1-yl)piperidin-1-yl]methyl} phenoxy)acetonitrile, 1-{ trans-4-[(3-hydroxyazetidin-1-yl)methyl]cyclohexyl} -1H-pyrrolo[3’,2’:5,6] pyrido[4,3-d]pyrimidine-2,4-(3H,7H)-dione, and 1-(trans-4-(hydroxymethyl)cyclohexyl)-1H-pyrrolo[2,3-h][1,6]naphthyridin-4(7H)-one. The compounds are inhibitors of Janus kinase (JAK). The compounds may be useful in the treatment of autoimmune, inflammatory and allergic diseases.
Patent NZ-712012-A (NZ)
Title: Pertuzumab variants and evaluation thereof
Inventor: GENNARO LYNN A
IPC: G01N33/53
Filed: 2014-04-15
Abstract: The present application discloses variants of Pertuzumab. In particular, it discloses: an unpaired cysteine variant comprising Cys23/Cys88 unpaired cysteines in one or both variable light domains of Pertuzumab, an afucosylated variant of Pertuzumab, a low-molecular-weight-species (LMWS) of Pertuzumab, and a high-molecular-weight-species (HMWS) or Pertuzumab. The application further discloses the isolated variants, compositions, pharmaceutical compositions, and articles of manufacture comprising the variants, as well as methods of making and characterizing the variants and compositions thereof.
Patent NZ-717110-A (NZ)
Title: Methods and apparatus for multiple user uplink
Inventor: MERLIN SIMONE
IPC: H04W72/00
Filed: 2014-08-27
Abstract: Methods and apparatus for multiple user uplink are provided. In one aspect, a method for wireless communication is provided. In an embodiment, a method includes transmitting a trigger frame to two or more stations, the trigger frame indicating an uplink transmission opportunity, the trigger frame message further comprising a request that the two or more stations concurrently transmit uplink data at a specific time, wherein the trigger frame comprises a duration field that indicates only a duration of a physical layer convergence protocol (PLCP) protocol data unit (PPDU) for a plurality of uplink data transmissions that the two or more stations are allowed to send. The method further includes receiving a plurality of uplink data from at least two stations at the specific time. Embodiments of the disclosure may provide an improved protocol for uplink transmissions from multiple terminals.
Patent NZ-726357-A (NZ)
Title: Device for prepositioning and removably attaching articulated limbs of a humanoid robot
Inventor: CLERC VINCENT
IPC: B25J19/00
Filed: 2015-06-01
Abstract: The invention relates to a mobile robot, taking into account, in the design of the robot, after-sale-related constraints, for example to allow easy diagnostics and simple and rapid repairability, the mobile robot comprising a trunk and several limbs removably linked to the trunk, the mobile robot further comprising: for each of the limbs, means for prepositioning said limb on the trunk, and a single flange linked to the trunk and configured to removably fix all the limbs to the trunk, wherein each of the limbs comprises a motorized articulation, via which said limb is positioned and fixed onto the trunk, and can be driven in movement relative to the trunk.
Patent NZ-735707-A (NZ)
Title: Iterative ray-tracing for autoscaling of oblique ionograms
Inventor: CROWLEY GEOFFREY
IPC: G01S19/07
Filed: 2016-02-25
Abstract: This invention relates generally to ionogram image processing, autoscaling and inversion systems and methods for ionospheric monitoring, modeling, and estimation of the same. One advantage of the present invention is to provide a system, e.g., a lightweight, low-power, and fully-autonomous ionospheric monitoring system that is able to provide fully processed and highly accurate ionosphere characterization in near real-time over a low data-rate satellite link.
Patent NZ-737326-A (NZ)
Title: Pyrido[3,4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof
Inventor: SASAKI KOSUKE
IPC: C07D471/04
Filed: 2016-05-27
Abstract: The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof.
Patent NZ-740106-A (NZ)
Title: Fertilizer composition comprising a humic agent, calcium sulfate, urea and ammonium sulfate
Inventor: PETER GLEN CAMPBELL
IPC: C05F11/00
Filed: 2018-02-26
Abstract: The present invention relates to a fertilizer composition, and to methods of using and blending the fertilizer composition. The fertilizer composition includes a humic agent, calcium sulfate, urea and ammonium sulphate. In the composition, the ratio of calcium sulfate : humic agent (by weight) is at least 2.75:1, the ratio of ammonium sulfate : humic agent (by weight) is at least 0.5:1, the composition includes at least 10% by weight calcium sulfate, the composition includes less than 6% by weight humic agent, and the composition is a solid. The composition is intended to be capable of improving the yield or growth characteristics of a crop, especially whilst minimising the amount of fertilizer that needs to be applied.
Patent NZ-751810-A (NZ)
Title: Process and apparatus for enhanced removal of contaminants in fluid catalytic cracking processes
Inventor: Tomsula Bryan
IPC: C10G11/18
Filed: 2017-09-15
Abstract: Systems for separating a contaminant trapping additive from a cracking catalyst may include a contaminant removal vessel having one or more fluid connections for receiving contaminated cracking catalyst, contaminated contaminant trapping additive, fresh contaminant trapping additive, and a fluidizing gas. In the contaminant removal vessel, the spent catalyst may be contacted with contaminant trapping additive, which may have an average particle size and/or density greater than the cracking catalyst. A separator may be provided for separating an overhead stream from the contaminant removal vessel into a first stream comprising cracking catalyst and lifting gas and a second stream comprising contaminant trapping additive. A recycle line may be used for transferring contaminant trapping additive recovered in the second separator to the contaminant removal vessel, allowing contaminant trapping additive to accumulate in the contaminant removal vessel. A bottoms product line may provide for recovering contaminant trapping additive from the contaminant removal vessel.
Patent NZ-754204-A (NZ)
Title: Object tracking system optimization and tools
Inventor: EVANSEN EDWARD
IPC: G06T7/20
Filed: 2014-06-04
Abstract: The object of this invention is to provide a method for automatically optimizing performance of an object tracking system. The method comprises receiving, within an optimizer, respective locations of a plurality of tags each of which is attached to an object tracked by the object tracking system, and then grouping identifiers of the tags within two or more tag sets based upon the locations. Each tag identified within a first tag set is configured with a first ping rate and tags identified within the other tag set/s are configured with a second ping rate less than the first ping rate. The first tag set identify tags located on a field of play and the other tag sets identify tags not located on the field of play. The first ping rate and the second ping rate are determined based upon a system bandwidth of the object tracking system, number of tags in the first tag set, and number of tags in the other of the two or more tag sets.
Patent NZ-781143-A (NZ)
Title: Anti-vegf protein compositions and methods for producing the same
Inventor: WANG SHUNHAI
IPC: C12N5/00
Filed: 2020-08-18
Abstract: The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions. A particular embodiment of the invention is a composition comprising oxo-aflibercept, wherein one or more amino acid residues of aflibercept is oxidized and wherein said one or more amino acid residues is histidine and/or tryptophan. This composition may undergo enzymatically digestion by trypsin resulting in one or more oligopeptides.
Patent PT-101751-A (PT)
Inventor: LAVON GARY DEAN
IPC: A61F13/00
Filed: 1995-08-04
Abstract: Disclosed are absorbent articles, such as diapers, for the management of incontinence. Such articles utilize in their absorbent cores an fluid acquisition/distribution component and a fluid storage/redistribution component maintained in fluid communication with the acquisition/distribution component. The fluid acquisition/distribution component can be any porous hydrophilic, e.g., fibrous or foam-based, material which will provide an initial Fluid Acquisition Rate of at least 2 mL of synthetic urine per second and will also preferably provide a 30-minute Vertical Wicking Height of at least 2 cm. The fluid storage/redistribution component comprises a hydrophilic, flexible, open-celled polymeric foam having a free absorbent capacity of at least about 12 mL of synthetic urine per gram of dry foam and an absorbent capacity under a 5.1 kPa confining pressure which is at least 5% of this free capacity. Preferred fluid acquisition/distribution component materials comprise chemically stiffened, twisted, curled cellulosic fibers. Preferred fluid storage/redistribution component materials comprise absorbent foams prepared by polymerizing a high internal phase emulsion (HIPE).
Patent PT-103983-A (PT)
Title: Composições constituídas por polissacarídeos com actividade anti-viral e anti-adesão bacteriana, respectivas formulações, processo de elaboração das mesmas e suas utilizações
Inventor: VIEIRA VITOR VERDELHO
IPC: A61P31/20
Filed: 2008-02-29
Abstract: A PRESENTE INVENÇÃO REFERE-SE A COMPOSIÇÕES CONTENDO UM OU, PREFENCIALMENTE, DOIS POLISSACARÍDEOS COM ACTIVIDADE ANTI-VIRAL E ANTI-ADESÃO BACTERIANA, AS QUAIS SÃO ÚTEIS NA PROFILAXIA E/OU NO TRATAMENTO DE VIROSES E BACTERIOSES, QUANDO UTILIZADAS EM QUANTIDADES TERAPEUTICAMENTE EFICAZES. OS POLISSACARÍDEOS SULFATADOS SÃO COMPOSTOS NATURAIS COM BAIXA TOXICIDADE PARA OS MAMÍFEROS E QUE APRESENTAM UMA ACTIVIDADE ANTI-VIRAL E ANTI-ADESÃO BACTERIANA ELEVADA, COMPREENDIDA ENTRE 1 MICROGRAMA/ML E 100 MICROGRAMAS/ML. AS REFERIDAS COMPOSIÇÕES TÊM COMO CARACTERÍSTICA ÚNICA A UTILIZAÇÃO DE DIVERSOS POLISSACARÍDEOS DE ORIGEM VEGETAL, OU OUTRA, ENTRE OS QUAIS SE DESTACA O POLISSACARÍDEO DE PHORPHYRIDIUM SP., COM UM INCORPORAÇÃO ENTRE 20 MICROGRAMAS/ML A 100 MICROGRAMAS/ML, O QUE PERMITE A REDUÇÃO DA ACTIVIDADE ANTI-VIRAL ENTRE 40-80% E, DA ADESÃO BACTERIANA, ENTRE 50%-70%, DEPENDENDO DAS SINERGIAS OBTIDAS PELAS DIFERENTES COMBINAÇÕES ENTRE OS DIFERENTES POLISSACARÍDEOS.AS REFERIDAS COMPOSIÇÕES, OBJECTO DA PRESENTE INVENÇÃO, PODEM SER UTILIZADAS NAS INDÚSTRIAS FARMACÊUTICA, COSMÉTICA, ALIMENTAR E DE RAÇÕES.
Patent PT-106991-A (PT)
Title: Saco de transporte a granel
Inventor: BARBATO IVANO
IPC: B65D88/22
Filed: 2013-06-07
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UM SACO FLEXÍVEL PRÓPRIO PARA O ARMAZENAMENTO E TRANSPORTE DE MATÉRIA-PRIMA A GRANEL, COMPREENDENDO UMA PARTE INTERIOR FECHADA (1) E PAREDES LATERAIS (2-5), QUE SUPORTA ATÉ UM PESO DE 24.000 KG, PERMITINDO O TRANSPORTE DE CARGA POR VIA FLUVIAL OU MARÍTIMA, QUANDO CARREGADO ATÉ UM PESO DE 15.000 KG, MANTENDO-SE A MESMA SECA DURANTE TODO O SEU PERCURSO. É COMPOSTO POR TRÊS CAMADAS DE COMPOSIÇÃO DISTINTA (6-8), SENDO A PRIMEIRA CAMADA EXTERIOR (6) CONSTITUÍDA POR UM TECIDO EM POLIPROPILENO E POLIETILENO, QUE SERVE DE REVESTIMENTO EM TODA A SUA ÁREA ENVOLVENTE E PROTEGE A CARGA TRANSPORTADA DE CHOQUES TÉRMICOS E HUMIDADE; A SEGUNDA CAMADA INTERIOR (7), QUE ENVOLVE TODA A SUPERFÍCIE DA EMBALAGEM, É COMPOSTA POR UMA ESPUMA EM POLIETILENO DE ALTA DENSIDADE, CAPAZ DE SUPORTAR CHOQUES E IMPACTOS; A TERCEIRA CAMADA (8) É CONSTITUÍDA POR FILME EM POLIETILENO DE ALTA DENSIDADE, PARA EFEITOS DE IMPERMEABILIZAÇÃO E CONFERÊNCIA DE RESISTÊNCIA AO SACO.